nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An active DNA vaccine against infectious pancreatic necrosis virus (IPNV) with a different mode of action than fish rhabdovirus DNA vaccines
|
Cuesta, A. |
|
2010 |
28 |
19 |
p. 3291-3300 10 p. |
artikel |
2 |
An inactivated West Nile Virus vaccine derived from a chemically synthesized cDNA system
|
Orlinger, Klaus K. |
|
2010 |
28 |
19 |
p. 3318-3324 7 p. |
artikel |
3 |
Anti-tumor immune response correlates with neurological symptoms in a dog with spontaneous astrocytoma treated by gene and vaccine therapy
|
Pluhar, G. Elizabeth |
|
2010 |
28 |
19 |
p. 3371-3378 8 p. |
artikel |
4 |
A probabilistic model for risk assessment of residual host cell DNA in biological products
|
Yang, Harry |
|
2010 |
28 |
19 |
p. 3308-3311 4 p. |
artikel |
5 |
A recombinant truncated FMDV 3AB protein used to better distinguish between infected and vaccinated cattle
|
He, Chunyan |
|
2010 |
28 |
19 |
p. 3435-3439 5 p. |
artikel |
6 |
Characterization of foot-and-mouth disease virus antigen by surface-enhanced laser desorption ionization-time of flight-mass spectrometry in aqueous and oil-emulsion formulations
|
Harmsen, M.M. |
|
2010 |
28 |
19 |
p. 3363-3370 8 p. |
artikel |
7 |
Characterizing the acceptability of a vaccine for West Nile virus by public health practitioners
|
Epp, Tasha |
|
2010 |
28 |
19 |
p. 3423-3427 5 p. |
artikel |
8 |
Codon-optimization of the hemagglutinin gene from the novel swine origin H1N1 influenza virus has differential effects on CD4+ T-cell responses and immune effector mechanisms following DNA electroporation in mice
|
Tenbusch, M. |
|
2010 |
28 |
19 |
p. 3273-3277 5 p. |
artikel |
9 |
Corrigendum to “Eliciting HIV-1 envelope-specific antibodies with mixed vaccinia virus recombinants” Vaccine 15 (1997) 265–272
|
Rencher, Samantha D. |
|
2010 |
28 |
19 |
p. 3507- 1 p. |
artikel |
10 |
Corrigendum to “Molecular epidemiology of G9 rotavirus strains in children with diarrhoea hospitalized in Mainland China from January 2006 to December 2007” [Vaccine 27 (Suppl. 5) (2009) 40–45]
|
Li, Dan-Di |
|
2010 |
28 |
19 |
p. 3506- 1 p. |
artikel |
11 |
Determinants of influenza immunization uptake in Canadian youths
|
Li, Zhuo |
|
2010 |
28 |
19 |
p. 3462-3466 5 p. |
artikel |
12 |
Editorial Board
|
|
|
2010 |
28 |
19 |
p. CO2- 1 p. |
artikel |
13 |
Effect of food coupon incentives on timely completion of DTP immunization series in children from a low-income area in Karachi, Pakistan: A longitudinal intervention study
|
Chandir, S. |
|
2010 |
28 |
19 |
p. 3473-3478 6 p. |
artikel |
14 |
Evaluating the Brighton Collaboration case definitions, aseptic meningitis, encephalitis, myelitis, and acute disseminated encephalomyelitis, by systematic analysis of 255 clinical cases
|
Rath, Barbara |
|
2010 |
28 |
19 |
p. 3488-3495 8 p. |
artikel |
15 |
Heterogeneity of hepatitis B transmission in Tunisia: Risk factors for infection and chronic carriage before the introduction of a universal vaccine program
|
Ben-Alaya-Bouafif, Nissaf |
|
2010 |
28 |
19 |
p. 3301-3307 7 p. |
artikel |
16 |
HSP65 serves as an immunogenic carrier for a diabetogenic peptide P277 inducing anti-inflammatory immune response in NOD mice by nasal administration
|
Liang, Jin |
|
2010 |
28 |
19 |
p. 3312-3317 6 p. |
artikel |
17 |
Hyporesponsiveness to re-challenge dose following pneumococcal polysaccharide vaccine at 12 months of age, a randomized controlled trial
|
Russell, F.M. |
|
2010 |
28 |
19 |
p. 3341-3349 9 p. |
artikel |
18 |
Immune response to intranasal and intraperitoneal immunization with Kaposi's sarcoma-associated herpesvirus in mice
|
Sakamoto, Kouta |
|
2010 |
28 |
19 |
p. 3325-3332 8 p. |
artikel |
19 |
Immunogenicity and some safety features of a VEGF-based cancer therapeutic vaccine in rats, rabbits and non-human primates
|
Morera, Yanelys |
|
2010 |
28 |
19 |
p. 3453-3461 9 p. |
artikel |
20 |
Impact of a single dose of the 7-valent pneumococcal conjugate vaccine on colonization
|
Frazão, Nelson |
|
2010 |
28 |
19 |
p. 3445-3452 8 p. |
artikel |
21 |
Innate and acquired immune responses induced by recombinant Lactobacillus casei displaying flagellin-fusion antigen on the cell-surface
|
Kajikawa, Akinobu |
|
2010 |
28 |
19 |
p. 3409-3415 7 p. |
artikel |
22 |
“Is cancer contagious?”: Australian adolescent girls and their parents: Making the most of limited information about HPV and HPV vaccination
|
Cooper Robbins, Spring Chenoa |
|
2010 |
28 |
19 |
p. 3398-3408 11 p. |
artikel |
23 |
Marker vaccine potential of a foot-and-mouth disease virus with a partial VP1 G-H loop deletion
|
Fowler, V.L. |
|
2010 |
28 |
19 |
p. 3428-3434 7 p. |
artikel |
24 |
Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster
|
Brisson, Marc |
|
2010 |
28 |
19 |
p. 3385-3397 13 p. |
artikel |
25 |
Report of the sixth AREB meeting, Manila, The Philippines, 10–12 November 2009
|
Dodet, B. |
|
2010 |
28 |
19 |
p. 3265-3268 4 p. |
artikel |
26 |
Serotype coverage of pneumococcal conjugate vaccine and drug susceptibility of Streptococcus pneumoniae isolated from invasive or non-invasive diseases in central Thailand, 2006–2009
|
Srifeungfung, Somporn |
|
2010 |
28 |
19 |
p. 3440-3444 5 p. |
artikel |
27 |
Squamous cell carcinoma of the oropharynx in Australian males induced by human papillomavirus vaccine targets
|
Hong, Angela M. |
|
2010 |
28 |
19 |
p. 3269-3272 4 p. |
artikel |
28 |
Standardization and validation of assays determining cellular immune responses against influenza
|
Gijzen, Karlijn |
|
2010 |
28 |
19 |
p. 3416-3422 7 p. |
artikel |
29 |
The Health Technology Assessment of bivalent HPV vaccine Cervarix ® in Italy
|
La Torre, Giuseppe |
|
2010 |
28 |
19 |
p. 3379-3384 6 p. |
artikel |
30 |
The Immunisation Beliefs and Intentions Measure (IBIM): Predicting parents’ intentions to immunise preschool children
|
Tickner, Sarah |
|
2010 |
28 |
19 |
p. 3350-3362 13 p. |
artikel |
31 |
The seroepidemiology of Bordetella pertussis in Israel—Estimate of incidence of infection
|
Rendi-Wagner, Pamela |
|
2010 |
28 |
19 |
p. 3285-3290 6 p. |
artikel |
32 |
Treatment of canine visceral leishmaniasis by the vaccine Leish-111f+MPL-SE
|
Trigo, Joelma |
|
2010 |
28 |
19 |
p. 3333-3340 8 p. |
artikel |
33 |
Trivalent Human Papillomavirus (HPV) VLP vaccine covering HPV type 58 can elicit high level of humoral immunity but also induce immune interference among component types
|
Zhang, Ting |
|
2010 |
28 |
19 |
p. 3479-3487 9 p. |
artikel |
34 |
Using oral polio vaccine beyond the cold chain: A feasibility study conducted during the national immunization campaign in Mali
|
Halm, Ariane |
|
2010 |
28 |
19 |
p. 3467-3472 6 p. |
artikel |
35 |
Vaccinations in children with cancer
|
Esposito, Susanna |
|
2010 |
28 |
19 |
p. 3278-3284 7 p. |
artikel |
36 |
Vaccination targeting surface FomA of Fusobacterium nucleatum against bacterial co-aggregation: Implication for treatment of periodontal infection and halitosis
|
Liu, Pei-Feng |
|
2010 |
28 |
19 |
p. 3496-3505 10 p. |
artikel |